| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8786520ca8c9bc7dbc704b8f4253deb2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-12 |
| filingDate |
1991-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f64104836b26deb5ab6ba5bff01a787 |
| publicationDate |
1992-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0472033-A2 |
| titleOfInvention |
3,5-Diiod-L-thyronin for TSH-suppression and the treatment of goiter |
| abstract |
The agent for TSH suppression and treatment of goiter contains a therapeutically effective dose of 3,5-diiod-L-thyronine and common pharmaceutical auxiliaries. The metabolite, which was previously thought to be ineffective, shows a strong effect on the TSH level without long-term administration without undesirable side effects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7723390-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005009433-A1 |
| priorityDate |
1990-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |